Baird Financial Group Inc. Sells 875 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Baird Financial Group Inc. decreased its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 13.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 5,654 shares of the biotechnology company's stock after selling 875 shares during the quarter. Baird Financial Group Inc.'s holdings in Axon Enterprise were worth $3,360,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of AXON. New Wave Wealth Advisors LLC acquired a new stake in shares of Axon Enterprise during the 4th quarter worth approximately $40,000. Y.D. More Investments Ltd acquired a new stake in shares of Axon Enterprise in the 4th quarter valued at $45,000. Stonebridge Financial Group LLC acquired a new stake in shares of Axon Enterprise in the 4th quarter valued at $53,000. GPS Wealth Strategies Group LLC raised its holdings in shares of Axon Enterprise by 74.1% during the 4th quarter. GPS Wealth Strategies Group LLC now owns 94 shares of the biotechnology company's stock worth $56,000 after buying an additional 40 shares in the last quarter. Finally, Berbice Capital Management LLC bought a new stake in shares of Axon Enterprise during the 4th quarter worth $59,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research firms have issued reports on AXON. JMP Securities reiterated an "outperform" rating on shares of Axon Enterprise in a research report on Tuesday, February 4th. Craig Hallum cut shares of Axon Enterprise from a "buy" rating to a "cautious" rating in a research report on Monday, March 10th. Needham & Company LLC raised their target price on shares of Axon Enterprise from $600.00 to $750.00 and gave the company a "buy" rating in a research report on Thursday. The Goldman Sachs Group upped their price target on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a "buy" rating in a report on Monday, January 27th. Finally, Barclays raised their price objective on Axon Enterprise from $726.00 to $735.00 and gave the company an "overweight" rating in a report on Friday. One research analyst has rated the stock with a sell rating, one has issued a hold rating and ten have issued a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $640.91.

Axon Enterprise Trading Down 0.3 %

Shares of AXON stock opened at $684.59 on Friday. The stock has a 50-day moving average of $564.50 and a 200-day moving average of $584.84. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The stock has a market cap of $53.29 billion, a price-to-earnings ratio of 176.90, a PEG ratio of 5.17 and a beta of 1.24. Axon Enterprise, Inc. has a 1-year low of $273.52 and a 1-year high of $715.99.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last released its quarterly earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.34 by $0.07. Axon Enterprise had a net margin of 15.37% and a return on equity of 7.50%. The firm had revenue of $603.63 million during the quarter, compared to analyst estimates of $585.67 million. During the same quarter last year, the business earned $1.15 EPS. The company's revenue was up 31.3% compared to the same quarter last year. On average, equities research analysts forecast that Axon Enterprise, Inc. will post 5.8 earnings per share for the current year.

Insider Activity at Axon Enterprise

In related news, CEO Patrick W. Smith sold 10,000 shares of the business's stock in a transaction on Monday, April 21st. The shares were sold at an average price of $540.99, for a total transaction of $5,409,900.00. Following the transaction, the chief executive officer now owns 3,063,982 shares in the company, valued at $1,657,583,622.18. The trade was a 0.33 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Jeri Williams sold 307 shares of the stock in a transaction on Monday, March 17th. The stock was sold at an average price of $552.72, for a total transaction of $169,685.04. Following the transaction, the director now directly owns 1,627 shares in the company, valued at approximately $899,275.44. This represents a 15.87 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 4.40% of the stock is owned by company insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXON - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.